Strategic action for overcoming drug resistance in malaria – 2018

This Call for proposals supports a large-scale strategic action (clinical research activities) that is part of a bigger portfolio of clinical trials with the capacity to develop new and diverse antimalarial drugs against Plasmodium falciparum and/or Plasmodium vivax, including combination therapies that may be used for treatment or chemoprevention of malaria in sub-Saharan Africa.

See the corresponding call text

Call identifier: RIA2018SD

PAMAFRICA
Portfolio approach to developing the next generation of malaria treatments for Africa

Medicines for Malaria Venture (MMV) Cointrin, Switzerland, with partners in Burkina Faso, Gabon, Germany, Mozambique, Spain, Switzerland, and Uganda.
Project coordinator: Dr Tim Wells (MMV)
Starting date: 01 January 2020
Duration: 60 months
EDCTP grant amount: EUR 21,990,938
Grant agreement: RIA2018SD-2306
Project website